Connect with us

Government

Infrastructure Shift Into 5G Would Fuel a Rally in These 3 Stocks

Shift Into 5G Could Fuel a Rally in These 3 Stocks

Published

3 years ago

on

This article was originally published by TipRanks.

The tech world is in the midst of a shake-up. Since the end of 2017, the new 5G wireless technology has been moving forward, bringing with it a combination of faster connection speeds and lower latency, and the promise of great changes in how we connect to the online world. New technologies – connected automobiles and agile IoT come to mind – would not be possible without 5G.

Investment research firm HSBC Global, in a recent report on the advent of 5G tech, takes up the questions of whether the new networking is a boom or a bust. Specifically, HSBC asks why 5G has been underwhelming – so far. Industry expert Professor William Webb notes that 5G’s rollout has not lived up to the hype, even in Asia where networks are more extensive and better integrated. He describes the technology as ‘evolutionary, not revolutionary.’

Webb points out several areas where 5G clearly needs further evolution: the expansion of networks, which will necessitate further buildouts of towers and cells; smoother transitions between cells; and improved functionality, once devices are connected. In his view, 5G is a beginning rather than an end.

Commenting on Webb’s views, and on the technology generally, HSBC's Head of Telecoms Neale Anderson, writes, “[We] see it as unfortunate (although sadly inevitable) that 5G was rushed to market... The bar will further be raised by mmWave services, which have been launched in the US, and recently in Asia in Japan. We see this as the ‘real’ 5G, and expect it to open up – albeit slowly – new opportunities for operators.”

Whether 5G underwhelms or overwhelms in the short term, in the longer term it is here to stay – and that means some stocks are going to gain as 5G expands. Wall Street’s analysts have been busy finding those stocks, and the TipRanks database has the scoop. Here are three of them.

Inseego Corporation (INSG)

First up, Inseego, is a wireless and mobile hotspot company. As can be imagined, the company has gained directly from the moves toward increased remote work and virtual offices. The stock is up 27% this year, even after accounting for high volatility in April and August.

Inseego has a direct concern in 5G. As a wireless provider, the company cannot afford to ignore the new tech, and is directly involved in developing and marketing home-use 5G routers. Inseego has an ongoing partnership with Verizon on networking and hardware, and is also working to expand its hotspots to IoT uses. The company has not ignored the innards of the devices, and works with Qualcomm on advanced 5G router chips.

Like many networking providers, Inseego has performed at the financial level. Quarterly revenues have posted sequential gains through 2020, with Q3 exceeding $90 million at the top line. Q3 EPS showed a loss of 6 cents; the loss was considered normal, as Inseego, again like many other tech firms, typically shows a net loss per share. The important point to the EPS was, it was the smallest such loss in two years.

Analyst Lance Vitanza, in his coverage of the stock for Cowen, writes, “While the company continues to see significant demand for legacy 4G products, its second-generation 5G product suite continues to ramp… Inseego is positioned to profit from the advent of 5G, technology that is estimated to generate $500 billion in GDP in the U.S. and which will give way to more traditional upgrades of existing mobile hot spots from 4G to 5G.”

In line with these comments, the analyst puts an Outperform (i.e. Buy) rating on the stock. His price target, at $13.50, indicates room for 44% growth in 2021. (To watch Vitanza’s track record, click here)

Overall, Inseego holds a Moderate Buy rating from the analyst consensus, based on 6 reviews breaking down to 4 Buys and 2 Holds. Meanwhile, the average price target, $13.17, suggests it has 41% upside potential in the year ahead. (See INSG stock analysis on TipRanks)

Amdocs Limited (DOX)

Software company Amdocs has built a strong reputation in the communications and media niche, while remaining under the radar compared to its competitors. In recent months, Amdocs has expanded its operations into 5G through the acquisition of Openet, a provider of telecom services for network commercialization and analytics. Openet bills itself as ‘built for 5G,’ and this acquisition, valued at $180 million, will bring Amdocs directing into the 5G network.

In the meantime, a look at Amdocs’ recent performance shows that the company holds a sound position in the software universe. The company’s revenues barely blinked through the corona crisis, remaining in the range of $1.03 to $1.05 billion for the past four quarters. Earnings did even better; the $1.17 EPS recorded in 3Q20 is the company’s highest in over two years.

Despite the solid financial performance, Amdocs shares have still not fully recovered from the mid-winter market crash. The stock is down 10% year-to-date, JPM analyst Jackson Ader believes that this stock’s relatively low price presents a clear opportunity for investors.

“As 5G adoption begins to pick up and North American revenue stabilizes we think it is time to step in to this value name that has significantly lagged our coverage and the market this year… we believe 5G tailwinds, improving cash flow conversion and a potential value rotation warrant an upgrade to Overweight,” Ader noted.

Along with that upgrade to Overweight (i.e. Buy), Ader sets a one-year price target of $75, suggesting a 17% upside for the stock. (To watch Ader’s track record, click here)

Overall, with 3 recent Buys and 1 Hold, Amdocs gets a Strong Buy rating from the analyst consensus. The stock is selling for $63.97 and the average price target is $76, slightly more bullish than Ader’s and implying an upside of ~19%. (See Amdocs stock analysis on TipRanks)

Tower Semiconductor (TSEM)

Last but not least is Tower Semiconductor, a fabrication company in the chip industry. Fabs are a vital link in the semiconductor business, as many of the big chip designers don’t actually manufacture their own products – they do the design, make the prototypes, and outsource the serial production. Tower is one of the serial producers, making chips for major names among the big semiconductor companies, including Broadcom, Intel, and Samsung.

Tower is heavily invested in 5G, producing a range of chips for 5G enabled devices, including everything from handsets to data centers. As 5G networks expand, and as end users begin the process of switching to enabled devices, Tower is well-positioned to gain. No matter which big chip companies get the lion’s share of the new business, Tower will be there – it runs the fabrication plants. It’s an enviable niche at a time when the market is starting to change at an accelerating rate.

The combination of a firm foundation and good prospects can be seen in the revenues and earnings outlook. At the top line, income has been stable through this pandemic year, while at the bottom line, EPS is projected to start swinging back up in Q4 of this year.

Needham analyst Rajvindra Gill is upbeat about Tower’s forward path. He rates the stock a Buy along with a $30 price target, suggesting a 30% upside on the one-year horizon. (To watch Gill’s track record, click here)

Backing his stance, Gill writes, “We expect robust growth in '21 given our expectations of the 5G smartphone market doubling and RF content increases of 40-60%... We view [TSEM] as our top small-cap 5G play, as we believe it is particularly well-positioned to benefit from the 5G cycle (both on smartphone & infrastructure side)."

All in all, Tower’s Strong Buy analyst consensus rating is unanimous, supported by 3 recent Buy reviews. The stock has an average price target of $27.67, which implies a 20% upside from the current share price of $23.08. (See TSEM stock analysis on TipRanks)

To find good ideas for 5G stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

The post Shift Into 5G Could Fuel a Rally in These 3 Stocks appeared first on TipRanks Financial Blog.

Read More

Related Topics:
Continue Reading

Government

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Submitted by Liam Cosgrove

Former…

Published

2 hours ago

on

March 12, 2024

By

Buried Project Veritas Recording Shows Top Pfizer Scientists Suppressed Concerns Over COVID-19 Boosters, MRNA Tech

Submitted by Liam Cosgrove

Former Project Veritas & O’Keefe Media Group operative and Pfizer formulation analyst scientist Justin Leslie revealed previously unpublished recordings showing Pfizer’s top vaccine researchers discussing major concerns surrounding COVID-19 vaccines. Leslie delivered these recordings to Veritas in late 2021, but they were never published:

Featured in Leslie’s footage is Kanwal Gill, a principal scientist at Pfizer. Gill was weary of MRNA technology given its long research history yet lack of approved commercial products. She called the vaccines “sneaky,” suggesting latent side effects could emerge in time.

Gill goes on to illustrate how the vaccine formulation process was dramatically rushed under the FDA’s Emergency Use Authorization and adds that profit incentives likely played a role:

"It’s going to affect my heart, and I’m going to die. And nobody’s talking about that."

Leslie recorded another colleague, Pfizer’s pharmaceutical formulation scientist Ramin Darvari, who raised the since-validated concern that repeat booster intake could damage the cardiovascular system:

None of these claims will be shocking to hear in 2024, but it is telling that high-level Pfizer researchers were discussing these topics in private while the company assured the public of “no serious safety concerns” upon the jab’s release:

Vaccine for Children is a Different Formulation

Leslie sent me a little-known FDA-Pfizer conference — a 7-hour Zoom meeting published in tandem with the approval of the vaccine for 5 – 11 year-olds — during which Pfizer’s vice presidents of vaccine research and development, Nicholas Warne and William Gruber, discussed a last-minute change to the vaccine’s “buffer” — from “PBS” to “Tris” — to improve its shelf life. For about 30 seconds of these 7 hours, Gruber acknowledged that the new formula was NOT the one used in clinical trials (emphasis mine):


“The studies were done using the same volume… but contained the PBS buffer. We obviously had extensive consultations with the FDA and it was determined that the clinical studies were not required because, again, the LNP and the MRNA are the same and the behavior — in terms of reactogenicity and efficacy — are expected to be the same.”

According to Leslie, the tweaked “buffer” dramatically changed the temperature needed for storage: “Before they changed this last step of the formulation, the formula was to be kept at -80 degrees Celsius. After they changed the last step, we kept them at 2 to 8 degrees celsius,” Leslie told me.

The claims are backed up in the referenced video presentation:

I’m no vaccinologist but an 80-degree temperature delta — and a 5x shelf-life in a warmer climate — seems like a significant change that might warrant clinical trials before commercial release.

Despite this information technically being public, there has been virtually no media scrutiny or even coverage — and in fact, most were told the vaccine for children was the same formula but just a smaller dose — which is perhaps due to a combination of the information being buried within a 7-hour jargon-filled presentation and our media being totally dysfunctional.

Bohemian Grove?

Leslie’s 2-hour long documentary on his experience at both Pfizer and O’Keefe’s companies concludes on an interesting note: James O’Keefe attended an outing at the Bohemian Grove.

Leslie offers this photo of James’ Bohemian Grove “GATE” slip as evidence, left on his work desk atop a copy of his book, “American Muckraker”:

My thoughts on the Bohemian Grove: my good friend’s dad was its general manager for several decades. From what I have gathered through that connection, the Bohemian Grove is not some version of the Illuminati, at least not in the institutional sense.

Do powerful elites hangout there? Absolutely. Do they discuss their plans for the world while hanging out there? I’m sure it has happened. Do they have a weird ritual with a giant owl? Yep, Alex Jones showed that to the world.

My perspective is based on conversations with my friend and my belief that his father is not lying to him. I could be wrong and am open to evidence — like if boxer Ryan Garcia decides to produce evidence regarding his rape claims — and I do find it a bit strange the club would invite O’Keefe who is notorious for covertly filming, but Occam’s razor would lead me to believe the club is — as it was under my friend’s dad — run by boomer conservatives the extent of whose politics include disliking wokeness, immigration, and Biden (common subjects of O’Keefe’s work).

Therefore, I don’t find O’Keefe’s visit to the club indicative that he is some sort of Operation Mockingbird asset as Leslie tries to depict (however Mockingbird is a 100% legitimate conspiracy). I have also met James several times and even came close to joining OMG. While I disagreed with James on the significance of many of his stories — finding some to be overhyped and showy — I never doubted his conviction in them.

As for why Leslie’s story was squashed… all my sources told me it was to avoid jail time for Veritas executives.

Feel free to watch Leslie’s full documentary here and decide for yourself.

Fun fact — Justin Leslie was also the operative behind this mega-viral Project Veritas story where Pfizer’s director of R&D claimed the company was privately mutating COVID-19 behind closed doors:

Tyler Durden Tue, 03/12/2024 - 13:40

Read More

Continue Reading

International

Association of prenatal vitamins and metals with epigenetic aging at birth and in childhood

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging…

Published

2 hours ago

on

March 12, 2024

By

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”

Credit: 2024 Bozack et al.

“[…] our findings support the hypothesis that the intrauterine environment, particularly essential and non-essential metals, affect epigenetic aging biomarkers across the life course.”

BUFFALO, NY- March 12, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 4, entitled, “Associations of prenatal one-carbon metabolism nutrients and metals with epigenetic aging biomarkers at birth and in childhood in a US cohort.”

Epigenetic gestational age acceleration (EGAA) at birth and epigenetic age acceleration (EAA) in childhood may be biomarkers of the intrauterine environment. In this new study, researchers Anne K. Bozack, Sheryl L. Rifas-Shiman, Andrea A. Baccarelli, Robert O. Wright, Diane R. Gold, Emily Oken, Marie-France Hivert, and Andres Cardenas from Stanford University School of Medicine, Harvard Medical School, Harvard T.H. Chan School of Public Health, Columbia University, and Icahn School of Medicine at Mount Sinai investigated the extent to which first-trimester folate, B12, 5 essential and 7 non-essential metals in maternal circulation are associated with EGAA and EAA in early life. 

“[…] we hypothesized that OCM [one-carbon metabolism] nutrients and essential metals would be positively associated with EGAA and non-essential metals would be negatively associated with EGAA. We also investigated nonlinear associations and associations with mixtures of micronutrients and metals.”

Bohlin EGAA and Horvath pan-tissue and skin and blood EAA were calculated using DNA methylation measured in cord blood (N=351) and mid-childhood blood (N=326; median age = 7.7 years) in the Project Viva pre-birth cohort. A one standard deviation increase in individual essential metals (copper, manganese, and zinc) was associated with 0.94-1.2 weeks lower Horvath EAA at birth, and patterns of exposures identified by exploratory factor analysis suggested that a common source of essential metals was associated with Horvath EAA. The researchers also observed evidence of nonlinear associations of zinc with Bohlin EGAA, magnesium and lead with Horvath EAA, and cesium with skin and blood EAA at birth. Overall, associations at birth did not persist in mid-childhood; however, arsenic was associated with greater EAA at birth and in childhood. 

“Prenatal metals, including essential metals and arsenic, are associated with epigenetic aging in early life, which might be associated with future health.”

 

Read the full paper: DOI: https://doi.org/10.18632/aging.205602 

Corresponding Author: Andres Cardenas

Corresponding Email: andres.cardenas@stanford.edu 

Keywords: epigenetic age acceleration, metals, folate, B12, prenatal exposures

Click here to sign up for free Altmetric alerts about this article.

 

About Aging:

Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Facebook
  • X, formerly Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Reddit
  • Pinterest
  • Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1

###

Journal

Aging-US

DOI

10.18632/aging.205602

Method of Research

Observational study

Subject of Research

People

Article Title

Associations of prenatal one-carbon metabolism nutrients and metals with epigenetic aging biomarkers at birth and in childhood in a US cohort

Article Publication Date

26-Feb-2024

Read More

Continue Reading

International

A beginner’s guide to the taxes you’ll hear about this election season

Everything you need to know about income tax, national insurance and more.

Published

2 hours ago

on

March 12, 2024

By

Cast Of Thousands/Shutterstock

National insurance, income tax, VAT, capital gains tax, inheritance tax… it’s easy to get confused about the many different ways we contribute to the cost of running the country. The budget announcement is the key time each year when the government shares its financial plans with us all, and announces changes that may make a tangible difference to what you pay.

But you’ll likely be hearing a lot more about taxes in the coming months – promises to cut or raise them are an easy win (or lose) for politicians in an election year. We may even get at least one “mini-budget”.

If you’ve recently entered the workforce or the housing market, you may still be wrapping your mind around all of these terms. Here is what you need to know about the different types of taxes and how they affect you.

The UK broadly uses three ways to collect tax:

1. When you earn money

If you are an employee or own a business, taxes are deducted from your salary or profits you make. For most people, this happens in two ways: income tax, and national insurance contributions (or NICs).

If you are self-employed, you will have to pay your taxes via an annual tax return assessment. You might also have to pay taxes this way for interest you earn on savings, dividends (distribution of profits from a company or shares you own) received and most other forms of income not taxed before you get it.

Around two-thirds of taxes collected come from people’s or business’ incomes in the UK.

2. When you spend money

VAT and excise duties are taxes on most goods and services you buy, with some exceptions like books and children’s clothing. About 20% of the total tax collected is VAT.

3. Taxes on wealth and assets

These are mainly taxes on the money you earn if you sell assets (like property or stocks) for more than you bought them for, or when you pass on assets in an inheritance. In the latter case in the UK, the recipient doesn’t pay this, it is the estate paying it out that must cover this if due. These taxes contribute only about 3% to the total tax collected.

You also likely have to pay council tax, which is set by the council you live in based on the value of your house or flat. It is paid by the user of the property, no matter if you own or rent. If you are a full-time student or on some apprenticeship schemes, you may get a deduction or not have to pay council tax at all.

Quarter life, a series by The Conversation

This article is part of Quarter Life, a series about issues affecting those of us in our 20s and 30s. From the challenges of beginning a career and taking care of our mental health, to the excitement of starting a family, adopting a pet or just making friends as an adult. The articles in this series explore the questions and bring answers as we navigate this turbulent period of life.

You may be interested in:

If you get your financial advice on social media, watch out for misinformation

Future graduates will pay more in student loan repayments – and the poorest will be worst affected

Selling on Vinted, Etsy or eBay? Here’s what you need to know about paying tax

Put together, these totalled almost £790 billion in 2022-23, which the government spends on public services such as the NHS, schools and social care. The government collects taxes from all sources and sets its spending plans accordingly, borrowing to make up any difference between the two.

Income tax

The amount of income tax you pay is determined by where your income sits in a series of “bands” set by the government. Almost everyone is entitled to a “personal allowance”, currently £12,570, which you can earn without needing to pay any income tax.

You then pay 20% in tax on each pound of income you earn (across all sources) from £12,570-£50,270. You pay 40% on each extra pound up to £125,140 and 45% over this. If you earn more than £100,000, the personal allowance (amount of untaxed income) starts to decrease.

If you are self-employed, the same rates apply to you. You just don’t have an employer to take this off your salary each month. Instead, you have to make sure you have enough money at the end of the year to pay this directly to the government.

Read more: Taxes aren't just about money – they shape how we think about each other

The government can increase the threshold limits to adjust for inflation. This tries to ensure any wage rise you get in response to higher prices doesn’t lead to you having to pay a higher tax rate. However, the government announced in 2021 that they would freeze these thresholds until 2026 (extended now to 2028), arguing that it would help repay the costs of the pandemic.

Given wages are now rising for many to help with the cost of living crisis, this means many people will pay more income tax this coming year than they did before. This is sometimes referred to as “fiscal drag” – where lower earners are “dragged” into paying higher tax rates, or being taxed on more of their income.

National insurance

National insurance contributions (NICs) are a second “tax” you pay on your income – or to be precise, on your earned income (your salary). You don’t pay this on some forms of income, including savings or dividends, and you also don’t pay it once you reach state retirement age (currently 66).

While Jeremy Hunt, the current chancellor of the exchequer, didn’t adjust income tax meaningfully in this year’s budget, he did announce a cut to NICs. This was a surprise to many, as we had already seen rates fall from 12% to 10% on incomes higher than £242/week in January. It will now fall again to 8% from April.

Read more: Budget 2024: experts explain what it means for taxpayers, businesses, borrowers and the NHS

While this is charged separately to income tax, in reality it all just goes into one pot with other taxes. Some, including the chancellor, say it is time to merge these two deductions and make this simpler for everyone. In his budget speech this year, Hunt said he’d like to see this tax go entirely. He thinks this isn’t fair on those who have to pay it, as it is only charged on some forms of income and on some workers.

I wouldn’t hold my breath for this to happen however, and even if it did, there are huge sums linked to NICs (nearly £180bn last year) so it would almost certainly have to be collected from elsewhere (such as via an increase in income taxes, or a lot more borrowing) to make sure the government could still balance its books.

A young black man sits at a home office desk with his feet up, looking at a mobile phone
Do you know how much tax you pay? Alex from the Rock/Shutterstock

Other taxes

There are likely to be further tweaks to the UK’s tax system soon, perhaps by the current government before the election – and almost certainly if there is a change of government.

Wealth taxes may be in line for a change. In the budget, the chancellor reduced capital gains taxes on sales of assets such as second properties (from 28% to 24%). These types of taxes provide only a limited amount of money to the government, as quite high thresholds apply for inheritance tax (up to £1 million if you are passing on a family home).

There are calls from many quarters though to look again at these types of taxes. Wealth inequality (the differences between total wealth held by the richest compared to the poorest) in the UK is very high (much higher than income inequality) and rising.

But how to do this effectively is a matter of much debate. A recent study suggested a one-off tax on total wealth held over a certain threshold might work. But wealth taxes are challenging to make work in practice, and both main political parties have already said this isn’t an option they are considering currently.

Andy Lymer and his colleagues at the Centre for Personal Financial Wellbeing at Aston University currently or have recently received funding for their research work from a variety of funding bodies including the UK's Money and Pension Service, the Aviva Foundation, Fair4All Finance, NEST Insight, the Gambling Commission, Vivid Housing and the ESRC, amongst others.

Read More

Continue Reading

Trending